Li Yan

Chief Tech/Sci/R&D Officer en Brii Biosciences Ltd. .

57 años

Health Technology

Consumer Services

Commercial Services

Perfil

Li Yan is currently the Chief Medical Officer at Brii Biosciences Ltd.
He previously worked as the Vice President at GSK Plc.
Prior to that, he was the Chief Medical Officer at Brii Biosciences Ltd.
(China) from 2018 to 2023.
Dr. Yan received his doctorate degree from the University of Kansas in 1996 and his undergraduate degree from Peking University Health Science Center in 1991.

Cargos activos de Li Yan

Empresas	Cargo	Inicio
Brii Biosciences Ltd. Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC.	Chief Tech/Sci/R&D Officer	-

Todos los cargos activos de Li Yan

Antiguos cargos conocidos de Li Yan.

Empresas	Cargo	Fin
BRII BIOSCIENCES LIMITED	Chief Tech/Sci/R&D Officer	05/07/2023
GSK PLC	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Li Yan.

Formación de Li Yan.

University of Kansas	Doctorate Degree
Peking University Health Science Center	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Li Yan.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
GSK PLC	Health Technology
BRII BIOSCIENCES LIMITED	Commercial Services

Empresas privadas	1
Brii Biosciences Ltd. Brii Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Brii Biosciences Ltd. is a biotechnology company, which engages in the provision of healthcare solutions. It focuses on the development of therapies for infectious diseases such as hepatitis B, COVID-19, human immunodeficiency virus (HIV) infection, multi-drug resistant (MDR) or extensive drug resistant (XDR) gram-negative infections, and other illnesses, such as the central nervous system (CNS) diseases. The company was founded by Zhi Hong in 2018 and is headquartered in Durham, NC.	Health Technology